Share on StockTwits

Immune Design Corp (NASDAQ:IMDZ) Director Franklin M. Berger purchased 50,000 shares of Immune Design Corp stock on the open market in a transaction that occurred on Tuesday, July 29th. The stock was purchased at an average cost of $12.00 per share, for a total transaction of $600,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $600,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Immune Design Corp (NASDAQ:IMDZ) remained flat at $12.00 during during mid-day trading trading on Thursday. The stock had a trading volume of 37,836 shares. Immune Design Corp has a one year low of $11.51 and a one year high of $12.81. The stock’s 50-day moving average is $12. and its 200-day moving average is $12.. The company’s market cap is $189.2 million.

Immune Design Corp is a clinical-stage immunotherapy company. The Company has engineered its technologies to activate the immune system’s natural ability to create tumor-specific cytotoxic T cells (NASDAQ:IMDZ), to fight cancer.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.